Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $141.38 (market cap $10.92B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is far larger — about 4.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and FormFactor Inc. FormFactor Inc. Common Stock is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| FORM | SLS | |
|---|---|---|
Market Cap | $10.92B | $2.28B |
Volume | 1,056,924 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $159.93 | $15.46 |
52-Week Low | $38.14 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $10.61B | $2.15B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
